Catalent Pharma Solutions has acquired Relthy Laboratórios in Brazil, expanding its softgel business and operations in South America. Relthy produces softgel encapsulated Vitamin, Mineral and Supplement (VMS) products, as well as prescription and OTC products for the Brazilian market. Relthy has 350 employees and a production capacity of two billion capsules per year. Relthy’s management team will join Catalent. Financial terms were not disclosed.   The acquisition provides Catalent entry into t...